Data from two studies show greater weight loss and comparable safety with a higher dose of semaglutide for those with and ...

Tirzepatide is more cost-effective than semaglutide for knee osteoarthritis and obesity, optimizing resources for patients ...

Tripling the weekly dose of semaglutide (Ozempic, Wegovy) resulted in greater weight loss compared with placebo in adults ...

Higher doses of weight loss medications like Ozempic and Wegovy could help treat obesity. In two new studies, people taking 7 ...

A new study suggests that some people taking the popular weight-loss drug Semaglutide may face an unexpected downside: loss ...

Semaglutide is currently administered through a weekly dose of up to 2.4 milligrams injected into the layer of fat over the ...

Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher ...

"For them to work effectively, they need to be taken long term," cautioned epidemiologisy professor Reimar W. Thomsen.

A multicenter collaboration of Danish researchers reports that once-weekly semaglutide for 30 weeks lowered blood sugar ...

People taking semaglutide report far fewer obsessive thoughts about food, with cravings dropping sharply and mental health ...

A Novo Nordisk-designed trial, conducted at 68 international hospitals, specialist clinics, and medical centers with ...

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart ...